Vertex Pharmaceuticals | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
AbbVie USD 18M 0 2024-12
Acadia Pharmaceuticals USD 16K 0 2024-12
Agios Pharmaceuticals USD 74K 1000 2025-03
Alnylam Pharmaceuticals USD 1.3M 10K 2025-03
Amgen USD 33.58B 45M 2025-03
Arrowhead Research USD 218K 1000 2024-12
Biogen USD 100K 0 2025-03
BioMarin Pharmaceutical USD 192K 1000 2025-03
Bristol-Myers Squibb USD 292M 0 2025-03
Gilead Sciences USD 1000K 0 2024-12
Incyte USD 193K 0 2025-03
Insmed USD 1.79M 6K 2024-12
Ionis Pharmaceuticals USD 159K 1000 2025-03
J&J USD 3.12B 0 2025-03
Merck USD 1.79B 0 2025-03
Moderna USD 38.7K 100 2025-03
Neurocrine Biosciences USD 100K 0 2024-12
Novartis USD 793M 0 2024-12
Pfizer USD 481M 1000K 2025-03
PTC Therapeutics USD 78K 1000 2025-03
Regeneron Pharmaceuticals USD 0 102K 2025-03
Roche Holding CHF 107M 0 2024-06
Sarepta Therapeutics USD 10K 0 2025-03
Ultragenyx Pharmaceutical USD 92K 0 2024-12
United Therapeutics USD 800K 0 2025-03
Vertex Pharmaceuticals USD 2.6M 0 2024-12



Vertex Pharmaceuticals Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.